IPPRA / Grant Monitor

2026-09-06
3129Open opportunities
1468Physical Sciences & Engineering (demo) ≥ 60
0Not yet characterized
580Awaiting detail
2026-09-05Last fetch
Lens
Deadline
Score
Funds
Topic
Category
Physical Sciences & Engineering (demo) fit Opportunity Topics Ceiling Posted Closes Days
25 Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) PAR-25-226 · National Institutes of Health · other biomedical clinical public health mental behavioral health 2024-11-22 2026-11-19 74
25 Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) PAR-27-012 · National Institutes of Health · other biomedical clinical public health mental behavioral health 2026-03-18 2028-11-02 788

2 OF 2 ROWS